tirzepatide court case update [March 7, 2025]: OFA takes to appeals as legal battle evolves FDA's tirzepatide decision creates uncertainty – Court Backs FDA in Tirzepatide

N Engl J Med 380:347357 Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK (2020) VERTIS CV Investigators

These applications fall outside general consumer guidelines and should follow professional recommendations

Ironing out macrophages in atherosclerosis

Mediators Inflamm (2014) 2014:162021.10.1155/2014/162021 191 CananiRBCostanzoMDLeoneLPedataMMeliRCalignanoA

It can also cause a "fishy" odor of the urine, breath, and sweat

Clinical trial data provides insight into the frequency of hair loss reported by people taking different GLP-1 and dual-agonist medications for weight management